Pfizer wins case against generic 'Viagra' pill-maker

An American company has been prevented from launching a generic version of Pfizer's erectile dysfunction pill Viagra until October 2019.

An American company has been prevented from launching a generic version of Pfizer's erectile dysfunction pill Viagra until October 2019.

The pharmaceutical giant has confirmed that it won a patent infringement case against the US unit of Teva Pharmaceuticals Industries.

You have reached your article limit. Already a subscriber? Sign in

185 years of the Irish Examiner

185th
Anniversary Offer

Six months of digital access for €18.50

No obligation. Ts&Cs apply.

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited